tag:blogger.com,1999:blog-8550428.post7548673873309461826..comments2024-03-27T01:34:23.434-04:00Comments on Pharma Marketing Blog: Pharma Marketing ROI: The Emperor Has No Clothes!Vladhttp://www.blogger.com/profile/04114063498108633047noreply@blogger.comBlogger3125tag:blogger.com,1999:blog-8550428.post-30060752326452418262008-03-30T19:51:00.000-04:002008-03-30T19:51:00.000-04:00The reason the data suppliers do not re-estimate m...The reason the data suppliers do not re-estimate media spending to a lower nunber is that each pharma company gets a different discount depending on volume. A small, one brand company spending $100 million would get less than Pfizer spending $400-500 million. So the measurement companies use one price for all. I know the amount of the discounts by polling the marketers and from my own experience at Parke-Davis on Lipitor. It was at least 40% less than was reported.Anonymousnoreply@blogger.comtag:blogger.com,1999:blog-8550428.post-3540519729420314202008-03-30T14:07:00.000-04:002008-03-30T14:07:00.000-04:00Possibly. But is it working?Possibly. But is it working?PharmaGuyhttps://www.blogger.com/profile/10211557578124130640noreply@blogger.comtag:blogger.com,1999:blog-8550428.post-49657544863261716732008-03-30T13:36:00.000-04:002008-03-30T13:36:00.000-04:00Is it possible that Lunesta's agressive marketing ...Is it possible that Lunesta's agressive marketing in '07 is a 'logical' reaction to category leader- Ambien's decline in marketshare since the launch of Ambien Generics in April 2007??Anonymousnoreply@blogger.com